23andMe Markets Genome Kits to Researchers

Scientists can now buy the direct-to-consumer sequencing product, and research participants can join 23andMe’s database.

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

YOUTUBE, ALEXTHEORGANICDirect-to-consumer genomics firm 23andMe is offering its spit-to-sequence kits to researchers for $199. Study volunteers can then join the company’s ancestry database and receive information on carrier status for diseases.

Duke University’s Ahmad Hariri, who has used the product for his research since 2009, gave The Verge a rave review. “It’s allowed us to maintain the highest quality of genotyping research without any need or necessity to have our own laboratory and our own staff,” he said.

While the service may ease the handling of the sample and analysis—23andMe can process kits sent directly to study participants and then give researchers raw genotyping data online—some balked at the price. Dan Arking of Johns Hopkins University told The Verge he typically spends $40 to $50 per sample for similar services through research consortiums that order in bulk.

One of the big appeals to using 23andMe is what volunteers get out of it. “We’ve enabled researchers to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies